Cargando…

Enzalutamide: A New Agent for the Prostate Cancer Treatment Armamentarium

Detalles Bibliográficos
Autor principal:	McCutcheon, Stephanie B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093421/ https://www.ncbi.nlm.nih.gov/pubmed/25031999

Ejemplares similares

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015)

Molecular mechanisms of enzalutamide resistance in prostate cancer
por: Blatt, Eliot B., et al.
Publicado: (2019)

Expanding the armamentarium for the spondyloarthropathies
por: Peloso, Paul M, et al.
Publicado: (2004)

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
por: Semenas, Julius, et al.
Publicado: (2013)

A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer
por: Greasley, Rosa, et al.
Publicado: (2015)

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
por: Yekedüz, Emre, et al.
Publicado: (2021)

The American Armamentarium Chirurgicum
Publicado: (1889)

Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer
por: Golshayan, Ali R, et al.
Publicado: (2013)

The Modern Surgical Armamentarium
Publicado: (1873)

Enzalutamide for patients with metastatic castration-resistant prostate cancer
por: Ramadan, Wijdan H, et al.
Publicado: (2015)

Armamentarium and Sterilization
por: ELEAZER, PAUL D.
Publicado: (2011)

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
por: El-Amm, Joelle, et al.
Publicado: (2013)

Mini-Implants in the Anchorage Armamentarium: New Paradigms in the Orthodontics
por: Yamaguchi, Masaru, et al.
Publicado: (2012)

Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
por: Rhea, Logan P, et al.
Publicado: (2019)

Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment
por: Attard, Gerhardt, et al.
Publicado: (2018)

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
por: Linder, Simon, et al.
Publicado: (2018)

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
por: Tucci, Marcello, et al.
Publicado: (2018)

Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
por: Kang, Borui, et al.
Publicado: (2023)

Lysins – a new armamentarium for the treatment of bone and joint infections?
por: Sendi, Parham, et al.
Publicado: (2022)

American Armamentarium Chirurgicum; Tieman
Publicado: (1889)

Acromegaly: Role of Surgery in the Therapeutic Armamentarium
por: Guinto, Gerardo, et al.
Publicado: (2012)

Regorafenib: Adding to the Armamentarium for Refractory Colorectal Cancer and GIST
por: Roman, Danielle, et al.
Publicado: (2013)

Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review
por: Shah, Yash B., et al.
Publicado: (2022)

Iris reconstruction: A perspective on the modern surgical armamentarium
por: Crawford, Alexandra, et al.
Publicado: (2021)

Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
por: Culig, Zoran
Publicado: (2017)

CBD as the New Medicine in the Pain Provider’s Armamentarium
por: Piermarini, Charlie, et al.
Publicado: (2019)

Bimekizumab: the new drug in the biologics armamentarium for psoriasis
por: Freitas, Egídio, et al.
Publicado: (2021)

Cinnamon in Anticancer Armamentarium: A Molecular Approach
por: Dutta, Anindita, et al.
Publicado: (2018)

Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer
por: Lopes, Nair, et al.
Publicado: (2021)

Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells
por: Singh, Saurabh Pratap, et al.
Publicado: (2020)

The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors
por: Bechman, Katie, et al.
Publicado: (2019)

Phase Analysis: A New Armamentarium in Nuclear Cardiology
por: Malik, Dharmender
Publicado: (2019)

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
por: Kim, Eileen S., et al.
Publicado: (2016)

Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer
por: Detert Oude Weme, S. E. H., et al.
Publicado: (2023)

Advanced prostate cancer – patient survival and potential impact of enzalutamide and other emerging therapies
por: Patel, Nihar K, et al.
Publicado: (2014)

Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
por: Schalken, Jack, et al.
Publicado: (2015)

Treatment Armamentarium of COVID-19: Evolving Strategies and Evidence So Far
por: Dhampalwar, Swapnil, et al.
Publicado: (2020)

The obstetrician's armamentarium: historical obstetric instruments and their inventors
por: Lawrence, Ghislaine M
Publicado: (2003)

Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer
por: Vander Ark, Alexandra, et al.
Publicado: (2018)

Molecular determinants for enzalutamide-induced transcription in prostate cancer
por: Yuan, Fuwen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4e6p8j9lmqe7mmsdl5p30rkric